Skip to main content
NNOX
NASDAQ Industrial Applications And Services

Nano-X Reports Q4 Loss, $15.5M Share Sale, and Warns of Future Financing Needs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.78
Mkt Cap
$181.722M
52W Low
$2.11
52W High
$5.86
52W Position info
32% above low
Off High info
53% below high
Rel. Volume info
3.0× avg
Market data snapshot near publication time

NNOX sits 32% above its 52-week low of $2.11 on elevated volume (3.0× avg).

Summary

Nano-X Imaging reported a significantly increased Q4 2025 net loss of $33.4 million, driven by a $17.5 million asset impairment, and disclosed a $15.5 million share issuance in Q4, while also warning of the need for additional future financing.


Key Events · Financing and Capital Events · NNOX

  • Increased Net Loss & Impairment

    Q4 2025 net loss surged to $33.4 million, up from $14.1 million in Q4 2024, largely due to a $17.5 million impairment charge from restructuring its South Korean manufacturing.

  • Significant Share Issuance

    The company sold approximately 4.2 million ordinary shares in Q4 2025, generating net proceeds of $15.5 million, indicating substantial dilution.

  • Liquidity Warning

    Nano-X explicitly stated it expects to need additional financing to implement its business plan, following negative cash flow from operations of $40.8 million in 2025.

  • New CFO Appointment

    Guy Nathanzon will replace Ran Daniel as Chief Financial Officer, effective August 1, 2026, bringing extensive financial leadership experience.


Analysis · NNOX · Industrial Applications And Services

This 6-K provides a critical update on Nano-X Imaging's financial health, revealing a substantial increase in net loss for Q4 2025, primarily due to a large asset impairment related to manufacturing restructuring. The company's negative cash flow from operations and explicit statement about needing additional financing highlight significant liquidity concerns. The disclosure of a $15.5 million share issuance in Q4 2025 indicates ongoing dilution to fund operations. While the company reported revenue growth and announced new distribution agreements for its Nanox.ARC systems and a new CFO, these positive operational developments are overshadowed by the pressing financial challenges and the need for further capital. Investors should monitor future financing activities and the pace of revenue generation from new deployments.

At the time of this filing, NNOX was trading at $2.78 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $181.7M. The 52-week trading range was $2.11 to $5.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NNOX - Latest Insights

NNOX
Jul 23, 2026, 5:30 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.974
Real-time Price: $0.900 info
Change: -$0.074 (-8%) info
Market Cap: $61.082M info
NNOX
Jul 23, 2026, 5:29 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.974
Real-time Price: $0.900 info
Change: -$0.074 (-8%) info
Market Cap: $61.082M info
NNOX
Jun 26, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.835749
Real-time Price: $0.900 info
Change: +$0.064251 (+8%) info
Market Cap: $61.082M info
NNOX
Jun 25, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $0.900 info
Change: -$0.616 (-41%) info
Market Cap: $61.082M info
NNOX
Jun 25, 2026, 8:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.900 info
Change: -$0.590 (-40%) info
Market Cap: $61.082M info